Lidocaine HCl Injection — Class I drug recall D-1248-2019
Terminated recall by Aurobindo Pharma USA Inc., reported 2019-04-17, distributed in NC, NM. Presence of Particulate Matter: One vial was found to contain a hair.
| Recall number | D-1248-2019 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurobindo Pharma USA Inc., East Windsor, NJ, United States |
| Recall initiated | 2019-03-28 |
| Classified | 2019-04-25 |
| Reported by FDA | 2019-04-17 |
| Terminated | 2024-04-11 |
| Distributed | NC, NM |
| Countries outside the US | MX |
| Quantity | 88,600 vials |
| Reason classes | specification failure |
| NDC | 00409-1159-18, 00517-0720-01, 55150-0162-05, 67777-0419-02, 76420-0782, 76420-0782-01 |
| Lot numbers | CLC180117 |
| Expiration dates | 2021-06-20 |
Product
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05
Reason for recall
Presence of Particulate Matter: One vial was found to contain a hair.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1248-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.